The increased prevalence of pigmentation disorders is anticipated to open up new avenues for the pigmentation disorders treatment market
![]() |
Pigmentation Disorders Treatment Market |
Market Overview:
Pigmentation disorders occur due to the abnormal production of melanin in the
skin that gives varied skin color. The products available in the pigmentation
disorders treatment market include creams, lasers, chemical peels, and
microdermabrasion that help reduce the severity of pigmentation. Some common
pigmentation disorders treated are melasma, vitiligo, freckles, age spots, and
post-inflammatory hyperpigmentation.
Market Dynamics:
There are two major drivers that are fueling growth of the pigmentation
disorders treatment market. Firstly, the increasing prevalence of pigmentation
disorders globally due to rising pollution levels and exposure to sun is
creating high demand for pigmentation disorders treatments. Secondly, the
introduction of new drugs and devices for pigmentation treatments is driving
the market growth. Some key innovations include combination therapy drugs,
microneedling, intense pulsed light therapy, and fractional laser resurfacing
treatments.
Segment Analysis
The global pigmentation disorders treatment market is dominated by the topical
drugs segment owing to its effectiveness and convenience of use. This segment
currently holds over 60% value share of the overall market and is expected to
remain dominant during the forecast period. Topical drugs are prescribed to be
applied on the affected areas of the skin to treat hyperpigmentation disorders
like melasma and post-inflammatory hyperpigmentation. Some of the commonly
prescribed topical drugs include hydroquinone, azelaic acid, kojic acid,
arbutin, and mercury.
PEST Analysis
Political: Regulations related to the sale and marketing approval of drugs and
medications for pigmentation disorders vary across countries. Stringent regulations
may delay drugs launches.
Economic: Rising disposable incomes in developing nations have increased
healthcare spending on aesthetic procedures, fueling market growth. However,
higher drug costs can limit widespread adoption.
Social: Growing social acceptability of aesthetic procedures and desire to look
visually appealing is a key driver. However, side effects and risks of
hydroquinone use have shifted preferences to herbal alternatives.
Technological: Adoption of advanced drug delivery systems like nanoemulsions,
liposomes, and microspheres help increase efficacy and comfort of topical
medications.
Key Takeaways
The global pigmentation disorders treatment market is expected to witness high
growth, exhibiting CAGR of 6.0% over the forecast period, due to increasing
preference for topical medications over oral drugs and laser treatments.
The Asia Pacific region is expected to witness the fastest growth during the
forecast period. Rising disposable incomes, growing social acceptability of
aesthetic treatments, and increasing influence of western beauty ideals are
driving market growth in the region.
Key players operating in the pigmentation disorders treatment market are Abbvie
Inc. (Allergan Inc.), Episciences Inc., L'ORÉAL SA (SkinCeuticals International),
and Pfizer Inc., among others. Major players are focusing on expanding their
product portfolios through acquisitions and new product launches. For instance,
in 2022, SkinCeuticals launched a new topical serum to reduce pigmentation.
Read
More:
https://www.marketwebjournal.com/pigmentation-disorders-treatment-market-demand-share-analysis/
Comments
Post a Comment